Paxlovid Weaker Against Current COVID-19 Variants

Printed for doctors to read in the conservative Medscape Journal from Sept. 22, 2023

A real-world study published in  JAMA Open Network  found that Pfizer's COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared to earlier studies. But when looking at death alone, the antiviral was still highly effective. 

Paxlovid was about 37% effective at preventing death or hospitali…